Efficacy and safety assessment of two schemes of oral administration of once-daily extended release metformin (metformin XR) in type 2 diabetic patients previously treated with metformin in combination with sulfonylurea. A 3-month, international, multicentre, randomised, double-blind, double-dummy, parallel group study.

Trial Profile

Efficacy and safety assessment of two schemes of oral administration of once-daily extended release metformin (metformin XR) in type 2 diabetic patients previously treated with metformin in combination with sulfonylurea. A 3-month, international, multicentre, randomised, double-blind, double-dummy, parallel group study.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Nov 2016

At a glance

  • Drugs Metformin (Primary) ; Sulfonylureas
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Mar 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 17 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top